An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital

Critical Care - Tập 22 - Trang 1-10 - 2018
Eli Ben-Chetrit1, Yonit Wiener-Well1, Emil Lesho2, Puah Kopuit1, Chaya Broyer3, Liora Bier1, Marc V. Assous4, Shmuel Benenson5, Matan J. Cohen6,7, Patrick T. McGann8, Erik Snesrud8, Phillip D. Levin3
1Infectious Diseases Unit, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel
2Infectious Diseases Unit, Rochester Regional Health, Rochester, USA
3General Intensive Care Unit, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel
4Clinical and Microbiology Laboratory, Shaare Zedek Medical Center, Hebrew University, Jerusalem, Israel
5Infectious Diseases Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel
6Clalit Health Services, Jerusalem, Israel
7Hebrew University, Jerusalem, Israel
8Multidrug-resistant Organism Repository and Surveillance Network, Walter Reed Army Institute of Research, Silver Spring, USA

Tóm tắt

Following a fatal intensive care unit (ICU) outbreak of carbapenem-resistant Acinetobacter baumanii (CRAB) in 2015, an aggressive infection control intervention was instituted. We outline the intervention and long-term changes in the incidence and prevalence of CRAB. The infection control intervention included unit closure (3 days), environmental cleaning, hand hygiene interventions, and environmental culturing. CRAB acquisition and prevalence and colistin use were compared for the 1 year before and 2 years after the intervention. Following the intervention, ICU CRAB acquisition decreased significantly from 54.6 (preintervention) to 1.9 (year 1) to 5.6 cases (year 2)/1000 admissions (p < 0.01 for comparisons with preintervention period.). Unexpectedly, ICU CRAB admission prevalence also decreased from 56.5 to 5.8 to 13 cases/1000 admissions (p < 0.001) despite the infection control intervention’s being directed at the ICU alone. In parallel, hospital CRAB prevalence decreased from 4.4 to 2.4 to 2.5 cases/1000 admissions (p < 0.001), possibly as a result of decreased discharge of CRAB carriers from the ICU to the wards (58.5 to 1.9 to 7.4 cases/1000 admissions; p < 0.001). ICU colistin consumption decreased from 200 to 132 to 75 defined daily dose (DDD)/1000 patient-days (p < 0.05). Hospital colistin consumption decreased from 21.2 to 19.4 to 14.1 DDD/1000 patient-days (p < 0.05). The ICU infection control intervention was highly effective, long-lasting, and associated with a decrease in last-line antibiotic use. The intervention was associated with the unexpected finding that hospital CRAB prevalence also decreased.

Tài liệu tham khảo